Abstract
BackgroundSuperlatives are exaggerative terms that may not accurately portray a treatment's effectiveness, safety, or availability. ObjectivesThe objective of this study was to evaluate the use of superlatives in news articles describing multiple sclerosis treatments. MethodsWe searched Google News for 11 prespecified superlative terms describing multiple sclerosis therapies in online news articles. ResultsWe found that news articles commonly describe non-FDA approved multiple sclerosis therapies with superlative terms without providing clinical evidence or attribution. Additionally, no articles were published on a HONcode certified webpage. ConclusionIt is important that healthcare professionals are aware of medical misinformation presented to the public.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
